Prevalence of β-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers

Revista Espanola de Quimioterapia

Volumn 19, Issue 2, 2006, Pages 144-151

  Messai, Y ^a   Benhassine, T ^a   Naim, M ^b   Paul, G ^c   Bakour, Rabah ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Hopital Central de l'Armee   (Algeria)

^c Institut Cochin   (France)

Author keywords

lactams; Escherichia coli; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORINASE; IMIPENEM; LATAMOXEF; MECILLINAM; MEZLOCILLIN; PENICILLINASE; TICARCILLIN; TIMENTIN;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ESCHERICHIA COLI; GENE AMPLIFICATION; HYDROLYSIS; ISOELECTRIC FOCUSING; ISOELECTRIC POINT; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE;

ALGERIA; BETA-LACTAM RESISTANCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 33746893414     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Macgowan, A.P., Brown, H.M., Holt, H.A. An eight-year survey of antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother 1993; 31: 543-557.
2. Philippen, A., Arlet, G., Jacoby, G.A. Plasmid-determined AmpC-type γ-lactamases. Antimicrob Agents Chemother 2002; 46: 1-11.
3. Jones, R.N. Important and emerging β-lactamases-mediated resistances in hospital-based pathogens; The AmpC enzymes. Diagn Microb Infect Dis 1998; 31: 461-466.
4. Livermore, D.M. β-Lactamase in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-584.
5. Dubois, S.K., Marriott, M.S., Amyes, S.G.B. TEM- and SHV-derived extended-spectrum β-lactamases: Relationship between selection, structure and function. J Antimicrob Chemother 1995; 35: 7-22.
6. Bauernfeind, A., Stemplinger, I., Jungwirth, R. et al. Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase. Antimicrob Agents Chemother 1996; 40: 616-620.
7. Poirel, L., Naas, T., Guibert, M., Chaibi, E., Labia, R., Nordmann, P. Molecular and biochemical characterisation of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother 1999; 43: 573-581.
8. Silva, J., Aguilar, C., Ayala, G. et al. TLA-I: A new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli. Antimicrob Agents Chemother 2000; 44: 997-1003.
9. Galani, I., Souli, M., Chryssouli, Z., Katsala, D., Giamarellou, H. first identification of an Escherichia coli clinical isolate producing both metallo-beta-lactamase VIM-2 and extended-spectrum beta-lactamase IBC-1. Clin Microbiol Infect 2004; 10: 757-760.
10. Bonnet, R. Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
11. Jacoby, A.J., Muñoz-Price, L.S. The new β-lactamases. N Engl J Med 2005; 352: 380-391.
12. TEM genes encoding β-lactamase resistance to clavulanic acid in clinical E. coli. J Mol Evol 1997; 44: 57-65.
13. Zhou, X.Y., Bordon, F., Sirot, D., Kitzis, M.D., Gutmann, L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamases inhibitors. Antimicrob Agents Chemother 1994; 38: 1085-1089.
14. Blasquez, J., Baquero, M.R., Canton, R., Alos, I., Baquero, F. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sublactam, and lazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1993; 37: 2059-2063.
15. Courvalin, P., Goldstein, F., Philipon, A., Sirot, J. (Eds.). L'antibiogramme. Ed. MPC-Vigot, Paris-Bruxelles 1985.
16. Communiqué du Comité de l'Antibiogramme de la Société Française de Microbiologie. 2005; http://www.sfm.asso.fr/
17. Livermore, D.M., Winstanley, T.G., Shannon, K.P. Interpretative reading: Recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 2001; 48 (Suppl. S1): 543-557.
18. Vedel, G. La lecture interprétative facteur de maîtrise de l'antibiogramme. Spectra Biologie 1997; 16: 465-478.
19. Jarlier, V., Nicolas, M.H., Fouraier, G., Philippon, A. Extended spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10: 867-878.
20. Bakour, R., Laroche, Y., Cornelis, G. Studies of the incompatibility and replication of the 70Kb virulence plasmids of Yersinia. Plasmid 1983; 10: 279-289.
21. Kado, C.I., Liu, S.T. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 45: 1365-1373.
22. Matthew, A., Harris, A.M., Marshall, M.J., Ross, G.W. The use of anaytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975; 88: 169-178.
23. Labia, R., Barthélémy, M. L'enzymogramme des béta-lactamases: Adaptation en gel de la technique iodométrique. Ann Inst Past Microbiol 1979; 130B: 295-304.
24. Smaoui, H., Mahjoubi, F., Boutiba, I. et al. Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): A multicenter study. Tunis Med 2003; 81: 390-394.
25. Bremer-Melchior, P., Gilly, L., Jugroot-Klotz, K., Bran, T., Nevot, P., Paul, G. Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli isolated in 1992 at the Cochin Hospital. Pathol Biol 1995; 43: 760-765.
26. Henquell, C., Sirot, D., Chanal, C. et al. Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in France. J Antimicrob Chemother 1994; 34: 707-714.
27. Gonlugur, U., Bakici, M.Z., Akkurt, I., Efeoglu T. Antibiotic susceptibility patterns among respiratory isolates of Gram-negative bacilli in a Turkish university hospital. BMC Microbiology 2004; 4: 32-37.
28. TEM genes. Antimicrob Agents Chemother 2000; 44: 2709-2714.
29. Kaye, K.S., Gold, S.H., Schwaber, M.J. et al. Variety of β-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States. Antimicrob Agents Chemother 2004; 48: 1520-1525.
30. Jeong, S.H., Bae, I.K., Kwon, S.B. et al. Dissemination of transferable CTX-M-type extended-spectrum β-lactamases-producing Escherichia coli in Korea. J Appl Microbiol 2005; 98: 921-927.
31. Kucukates, E. Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in Cardiology Institute in Istanbul. Turkey. Jpn J Infect Dis 2005; 58: 228-231.
32. Oteo, J., Campos, J., Baquero, F. and Spanish members of the European Antimicrobial Surveillance System. Antibiotic resistance in 1,962 invasive isolates of Escherichia coli in 27 Spanish hospitals participing in the European Antimicrobial Surveillance System (2001). J Antimicrob Chemother 2002; 50: 945-952.
33. Fluit, A.C., Jones, M.E., Schmitz, M.E., Acar, J., Gupta, R., Verhoef, J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from SENTRY antimicrobial surveillance program, 1997-1998. Clin Infect Dis 2000; 30: 454-460.
34. Wenzel, R.P., Sahm, D.F., Thornsberry, C.D., Raghi, D.C., Jones, M.E., Karlowsk, J. A. In vitro susceptibilities of Gram-negative bacteria isolated from hospitalized patients in four European countries. Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: Implications for therapy. Antimicrob Agents Chemother 2003; 47: 3089-3098.
35. Martínez, J.L., Vicente, M.F., Delgado-Iribarren, A., Pérez-Díaz, J.C., Bacquero, F. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob. Agents Chemother 1989; 33: 595.
36. Medeiros, A.A. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997; 24 (Suppl.): 19-45.
37. Bush, K., Jacoby, G.A., Medeiros, A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-1233.
38. Tankhiwale, S.S., Jalgaonkar, S.V., Ahamad, S., Hassani, U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res 2004; 120: 553-556.
39. Gangoué-Piéboji, J., Bedenic, B., Koulla-Shiro, S. et al. Extended-spectrum β-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 2005; 37: 3273-3277.
40. Edelstein, M., Pimkin, M., Palagin, I., Edelstein, I., Stratchounski, L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47: 3724-3732.
41. Ryoo, N.H., Kim, E.-C., Hong, S.G. et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005; 56: 698-702.
42. Mulvey, M.R., Bryce, E., Boyd, D. et al. and the Canadian Hospital Epidemiology Committee of the Canadian Nosocomial Infection Surveillance Program, Health Canada. Ambler class A extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 2004; 48: 1204-1214.
43. Nijssen, S., Florijn, A., Bonten, M.J., Schmitz, F.J., Verhoef, J., Fluit, A.C. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5,000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004; 24: 585-591.
44. Daoud, Z., Hakim, N. Prevalence and susceptibility patterns of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon. Rev Esp Quimioter 2003; 16: 233-238.
45. Winokur, P.L., Canton, R., Casellas, J.M., Legakis, N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32 (Suppl. 2): S94-S103.
46. Naas, T., Lezzar, A., Bentchouala, C. et al. Multidrug-resistant Salmonella enterica serotype Senftenberg isolates producing CTX-M β-lactamases from Constantine, Algeria. J Antimicrob Chemother 2005; 56: 439-440.
47. Pitout, J.D., Laupland, K.B., Church, D.L., Menard, M.L., Johnson, J.R. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 47: 4667-4670.
48. Cao, V., Lambert, T., Courvalin, P. ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17. Antimicrob Agents Chemother 2002; 46: 1212-1217.
49. Dimitrov, T.S., Udo, E.E., Verghese, T., Emara, M., Al-Saleh, A. Plasmid-mediated high-level ceftriaxone resistance in a Salmonella enterica serotype typhimurium isolate. Med Princ Pract 2006; 15: 145-148.
50. Tassios, P.T., Gazouli, M., Tzelepi, E. et al. Spread of Salmonella typhimurium clone resistant to extended-spectrum cephalosporins in three European countries. J Clin Microbiol 1999; 37: 3774-3777.
51. Karim, A., Poirel, S., Nagarajan, S., Nordman, P. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001; 201: 237-241.
52. CTX-M-9. Antimicrob Agents Chemother 2002; 46: 2656-2661.
53. Álvarez, M., Tran, J.H., Chow, N., Jacoby, G.A. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004; 48: 533-537.
54. Mulvey, R.M., Brice, E., Boyd, D.A. et al. and the Canadian Hospital Epidemiology Committee of the Canadian Nosocomial Infection Surveillance Program, Health Canada. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 2005; 49: 358-365.
55. Wang, Q.T., Liu, Y.M., Wang, H., Sun, H.L., Chen, M.J., Du, X.L. Plasmid-mediated cephalosporinase among extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae. Zhongua Nei Ke Za Zhi 2004; 43: 487-490.
56. Gazouli, M., Tzouvelekis, L.S., Vatopoulos, A.C., Tzelepi, E. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase. J Antimicrob Chemother 1998; 42: 419-425.
57. Chen, H.Y., Livermore, D.M. Activity of cefepime and other β-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 1993; 32 (Suppl. B): 63-74.